India provides comprehensive leukemia treatment including chemotherapy, targeted therapy, and advanced bone marrow transplants. Major centers offer CAR T-cell therapy and immunotherapy for complex cases. These facilities maintain high standards with Joint Commission International and National Accreditation Board for Hospitals & Healthcare Providers certifications. Treatment typically occurs in specialized oncology units.
- Chemotherapy: Protocols include induction, consolidation, and maintenance phases to ensure remission.
- Targeted therapy: Doctors use specialized drugs like Tyrosine Kinase Inhibitors for specific genetic mutations.
- Bone marrow transplant: High-risk cases receive allogeneic or autologous transplants in HEPA-filtered units.
- CAR T-cell therapy: Select centers provide advanced cellular therapy for relapsed B-cell lymphoblastic leukemia.
Bookimed Expert Insight: India has become a global leader in accessible hematology care. Dr. Rahul Bhargava at Fortis Memorial Research Institute has performed over 1,000 stem cell transplants. He even helped establish 10 low-cost transplant centers across the country. Patients can find highly concentrated expertise in Delhi and Gurgaon. Clinics there like Apollo and Artemis serve over 1,000,000 patients annually. This high volume ensures medical teams are well-versed in managing rare leukemia subtypes.
Patient Consensus: Patients note it is vital to plan travel to metro cities for initial treatment. They emphasize that the first two months require very intensive monitoring and better ICU support.